Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$42.5B |
| 2 |
NVIDIA
NVDA
|
+$2.39B |
| 3 |
Walmart Inc
WMT
|
+$1.17B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 5 |
JPMorgan Chase
JPM
|
+$808M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.26B |
| 2 |
Amazon
AMZN
|
+$843M |
| 3 |
Xcel Energy
XEL
|
+$674M |
| 4 |
Global Payments
GPN
|
+$623M |
| 5 |
Palantir
PLTR
|
+$577M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 46.22% |
| 2 | Technology | 18.11% |
| 3 | Financials | 7.1% |
| 4 | Communication Services | 5.53% |
| 5 | Consumer Discretionary | 5.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
UCTT
1626
Ultra Clean Holdings
UCTT
$3.56B
| $7.01M | ﹤0.01% |
112,679
+43,024
| +62% | +$2.21M |
2016 Q2
39 quarters
|
|
|
WCC
1627
WESCO International
WCC
$18.1B
| $7M | ﹤0.01% |
25,593
-15,778
| -38% | -$4.43M |
2013 Q2
51 quarters
|
|
1628
Post Holdings
POST
$3.3B
| $6.99M | ﹤0.01% |
70,695
+24,904
| +54% | +$2.54M |
2013 Q2
51 quarters
|
|
1629
Albertsons Companies
ACI
$5.69B
| $6.98M | ﹤0.01% |
409,461
-788,604
| -66% | -$13.7M |
2020 Q2
23 quarters
|
|
1630
MaxLinear
MXL
$8.35B
| $6.97M | ﹤0.01% |
401,059
-243,311
| -38% | -$4.37M |
2022 Q2
15 quarters
|
|
1631
BioMarin Pharmaceuticals
BMRN
$11.3B
| $6.94M | ﹤0.01% |
122,838
-165,709
| -57% | -$9.66M |
2013 Q2
51 quarters
|
|
1632
Corcept Therapeutics
CORT
$12.3B
| $6.94M | ﹤0.01% |
172,078
+140,915
| +452% | +$5.27M |
2016 Q2
39 quarters
|
|
1633
CALL
Workday
WDAY
$45B
| $6.92M | ﹤0.01% |
53,300
+49,200
| +1,200% | +$7.81M |
2025 Q3
2 quarters
|
|
1634
CALL
Cytokinetics
CYTK
$9.12B
| $6.9M | ﹤0.01% |
104,700
-27,500
| -21% | -$1.75M |
2025 Q2
3 quarters
|
|
1635
SFL Corp
SFL
$1.87B
| $6.89M | ﹤0.01% |
638,532
+449,314
| +237% | +$4.35M |
2022 Q1
16 quarters
|
|
1636
Enovis
ENOV
$1.04B
| $6.86M | ﹤0.01% |
301,389
-17,114
| -5% | -$405K |
2013 Q2
51 quarters
|
|
1637
Central Garden & Pet Co Class A
CENTA
$2.12B
| $6.86M | ﹤0.01% |
211,446
-80,751
| -28% | -$2.58M |
2016 Q1
40 quarters
|
|
|
EMA
1638
Emera Inc
EMA
$14.6B
| $6.84M | ﹤0.01% |
131,784
-110,925
| -46% | -$5.62M |
2025 Q2
3 quarters
|
|
1639
Clean Harbors
CLH
$16.5B
| $6.81M | ﹤0.01% |
23,752
-16,842
| -41% | -$4.6M |
2013 Q2
51 quarters
|
|
1640
CarMax
KMX
$7.93B
| $6.79M | ﹤0.01% |
163,225
-159,348
| -49% | -$6.98M |
2013 Q2
51 quarters
|
|
1641
CALL
Sunrun
RUN
$1.84B
| $6.78M | ﹤0.01% |
500,000
-903,400
| -64% | -$15M |
2023 Q4
9 quarters
|
|
1642
Old Republic International
ORI
$9.05B
| $6.76M | ﹤0.01% |
169,409
-192,062
| -53% | -$7.9M |
2013 Q2
51 quarters
|
|
|
NBIS
1643
PUT
Nebius Group N.V.
NBIS
$63.1B
| $6.72M | ﹤0.01% |
64,800
-205,700
| -76% | -$20.5M |
2025 Q1
4 quarters
|
|
1644
Equinox Gold
EQX
$12.6B
| $6.72M | ﹤0.01% |
464,556
-10,800
| -2% | -$165K |
2022 Q1
16 quarters
|
|
1645
Lincoln Electric
LECO
$14.7B
| $6.7M | ﹤0.01% |
26,895
-12,679
| -32% | -$3.39M |
2013 Q2
51 quarters
|
|
1646
Fortune Brands Innovations
FBIN
$4.6B
| $6.68M | ﹤0.01% |
171,508
-80,786
| -32% | -$4.2M |
2013 Q2
51 quarters
|
|
1647
American Healthcare REIT
AHR
$11.1B
| $6.66M | ﹤0.01% |
141,292
-176,366
| -56% | -$8.74M |
2024 Q2
7 quarters
|
|
1648
Champion Homes
SKY
$4.75B
| $6.65M | ﹤0.01% |
89,423
-73,265
| -45% | -$6.31M |
2018 Q3
30 quarters
|
|
1649
PUT
CleanSpark
CLSK
$3.22B
| $6.64M | ﹤0.01% |
+780,000
| New | +$8.34M |
2026 Q1
0 quarters
|
|
1650
McEwen Inc
MUX
$1.08B
| $6.61M | ﹤0.01% |
323,606
+179,124
| +124% | +$4.25M |
2025 Q4
1 quarter
|
|
Similar funds
Barclays's Q1 2026 Portfolio in Review
As of Q1 2026, Barclays held 5,572 positions worth $416B, down 0.11% from $417B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays deployed $42.4B of net new capital in Q1 2026, opening 397 new positions and adding to 1,219 existing holdings. Its largest new stake was Sunbelt Rentals Holdings: 1,528,635 shares worth $99.5M.
By sector, the portfolio is most concentrated in Miscellaneous at 46% of assets, up from 44% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Tesla, an estimated $1.26B trimmed.
- Barclays's largest Q1 2026 buy was Sunbelt Rentals Holdings: 1,528,635 shares worth $99.5M.
- Barclays added most to iShares MSCI Emerging Markets ETF in Q1 2026, an estimated $42.5B increase.
- Barclays's biggest Q1 2026 reduction was Tesla, cutting an estimated $1.26B.
- Barclays fully exited CyberArk in Q1 2026, selling an estimated $232M.
- Barclays's ten largest holdings make up 37% of its $416B portfolio in Q1 2026.
- Barclays opened 397 new positions and closed 563 in Q1 2026.
- Barclays's portfolio value fell 0.11% quarter-over-quarter to $416B.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.